Bhopal Newspaper

Synthetic Biology Market Size is Projected to Reach $20.1 billion by 2025, Growing at a CAGR of 24.2%

 Breaking News
  • No posts were found

Synthetic Biology Market Size is Projected to Reach $20.1 billion by 2025, Growing at a CAGR of 24.2%

April 20
23:12 2020
Synthetic Biology Market Size is Projected to Reach $20.1 billion by 2025, Growing at a CAGR of 24.2%
Synthetic Biology Market by Tool, by Technology, by Application, By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2020-2025

The Global Synthetic Biology Market is estimated to grow at a CAGR of 24.2% during the forecast period 2020-2025. As per the analysis, the Global Synthetic Biology Market valued $6.8 billion in the year 2020 and estimated to reach $20.1 billion by the end of the year 2025.

The Global Synthetic Biology Market growth is driven by various growth factors such as increasing investments by government and private players in synthetic biology, increasing R&D funding & initiatives in synthetic biology, declining cost of DNA sequencing & synthesizing, wide range of applications of synthetic biology and growth in demand for synthetic cells and synthetic genes.

DOWNLOAD SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC88

Segmentation Overview of the Global Synthetic Biology Market

The global synthetic biology market is segmented on the basis of tool, technology and application. These market segments are categorized into various sub-segments to study the market in detail.

The Tool Segment of the Global Synthetic Biology Market is Sub-Segmented into:

  • Xeno-nucleic Acids
  • Oligonucleotides and Synthetic DNA
  • Cloning Technologies Kits
  • Chassis Organisms
  • Enzymes
  • Synthetic Cells

The Technology Segment of the Global Synthetic Biology Market is Sub-Segmented into:

  • Nanotechnology
  • Sequencing
  • Microfluidics
  • Measurement and Modelling
  • Site-directed Mutagenesis
  • Bioinformatics
  • Cloning
  • Genome Engineering
  • Gene Synthesis

The Application Segment of the Global Synthetic Biology Market is Sub-Segmented into:

  • Biofuel and Renewable Energy
  • Industrial Applications
  • Pharmaceuticals
  • Medical Application
  • Drug Discovery and Therapeutics
    • Cancer Detection & Diagnostics
    • Other Drug Discovery and Therapeutic Applications
    • Artificial Tissue and Tissue Regeneration
      • Stem Cell Regulation
      • Bio-synthesis
      • Other Tissue and Tissue Regeneration Applications
      • Biomaterials and Green Chemicals
      • Industrial Enzymes, by Application
        • Paper Industry
        • Textile Industry
        • Other Industries
        • Biosensing
        • Environmental Applications
        • Food & Agriculture
        • Bioremediation

Geographical Overview of the Global Synthetic Biology Market

On the basis of geographical segmentation, the global synthetic biology market was studied across North America (U.S., Canada); Europe (Germany, UK, France); Asia Pacific (China, India, Japan); Latin America (Brazil, Mexico); Middle East & Africa. As per the analysis, the Asia-Pacific synthetic biology market is estimated to grow at the highest CAGR during the forecast period 2020-2025. The regional growth is attributed to growth in the number of pharmaceutical & biopharmaceutical companies, strong government support, heavy funding for synthetic biology research, increasing number of international alliances, increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies and increasing number of healthcare & life science facilities in the region.

Key Players Insights

New England Biolabs (US), Integrated DNA Technologies, Inc. (US), Arzeda (US), TeselaGen (US), ATUM (US), Cyrus Biotechnology Inc. (US), Eurofins Scientific (Luxembourg), Creative Enzymes (US), Synthego Corporation (US), Codexis, Inc. (US), Synthetic Genomics, Inc. (US), Twist Bioscience (US), GenScript Biotech Corporation (China), Intrexon Corporation (US), Amyris, Inc. (US), Ginkgo Bioworks (US), Novozymes A/S (Denmark), Agilent Technologies, Inc. (US), Merck KGaA (Germany) and Thermo Fisher Scientific Inc. (US) are some major players included in the research study of the global synthetic biology market. The key players present in the market are adopting various competitive strategies to withhold the market share for the long-term. Some of the competitive strategies are business expansions, mergers and acquisitions, partnerships, collaborations and many more. For instance:

Recent Developments

December 2019, Product Launch: Amyris launched a brand sweetener Purecane for the health-conscious consumer segment of the company. Amyris develop and produce sustainable ingredients for the Flavours & Fragrances, Health and Clean Beauty Industry.

December 2019, Collaboration: Cyrus Biotechnology entered into an agreement to collaborate with Harvard and MIT to optimize CRISPR in developing human therapeutics.

June 2019, Business Expansion: Novozymes opened its another campus in Lyngby based in Copenhagen. The company adopted this expansion strategy with the focus to create a hub for biotech research at the global level.

GET FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC88

Media Contact
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Phone: +91-9997112116
Address:Classic Tower, Rajnagar Extension
City: Ghaziabad
State: UP, 201017
Country: India
Website: www.reportocean.com

Related Articles